
Kadriye Baskurt/LinkedIn
Aug 27, 2025, 17:11
Kadriye Baskurt: A New Era in Perioperative Gastric Cancer Management
Kadriye Baskurt, Medical Oncologist at Etlik City Hospital, shared on X:
“Breaking NCCN Update (v3.2025)
- FLOT remains Cat.1 standard for resectable gastric/GEJ adenocarcinoma
- Durvalumab + FLOT → now Cat.1 option for PD-L1 CPS ≥1 or TAP ≥1 tumors
- PD-L1 testing recommended universally, not only in advanced disease
- Supported by MATTERHORN trial, demonstrating significant EFS benefit
A new era in perioperative gastric cancer management.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 27, 2025, 20:41
Aug 27, 2025, 20:22
Aug 27, 2025, 20:08
Aug 27, 2025, 20:01
Aug 27, 2025, 19:51
Aug 27, 2025, 19:42
Aug 27, 2025, 19:33
Aug 27, 2025, 19:21
Aug 27, 2025, 19:03